DocGo (DCGO) Q4 2025: SteadyMD Revenue Jumps $8M, Driving 2026 Guidance Upside
DocGo’s integration of SteadyMD and operational gains in medical transportation are reshaping its margin outlook and topline profile. The company’s exit from migrant-related programs is now complete, focusing results on recurring, higher-margin core segments. 2026 guidance was raised for both revenue and EBITDA loss, with a clear path to profitability in the second half as efficiency projects and automation take hold.
Summary
- SteadyMD Integration Accelerates: Virtual care volumes and margin expansion are now central to DocGo’s growth thesis.
- Labor and Technology Drive Margin: Improved EMT hiring and automation initiatives are unlocking operational leverage.
- Profitability Path in Focus: Management expects to reach adjusted EBITDA breakeven in the second half of 2026.
Performance Analysis
DocGo’s Q4 results reflect a strategic pivot away from volatile migrant programs toward durable, higher-quality recurring revenue streams. Total revenue declined year-over-year due to the wind-down of migrant contracts, but core business lines—medical transportation and mobile health—demonstrated robust organic growth when excluding these one-off contracts. Notably, SteadyMD, the virtual care acquisition, contributed $6.1 million in Q4 and surpassed $8 million in quarterly revenue for the first time, highlighting its rapid trajectory.
Medical transportation revenue grew on the back of improved hiring and reduced overtime costs, with trips up 11% year-over-year. Mobile health, excluding migrant revenue, posted 47% growth led by care gap closure, remote patient monitoring, and mobile phlebotomy. Segment gross margins were mixed: transportation margins improved to 32.8%, while mobile health margins were temporarily diluted by wind-down costs but are expected to rebound as the business mix shifts further toward higher-margin services. Adjusted EBITDA loss was elevated by non-recurring wind-down expenses, but underlying profitability is improving.
- SteadyMD Outperformance: Surpassed $8M in Q4 revenue, exceeding previous highs and driving virtual care momentum.
- Transportation Margin Recovery: Overtime rates are declining, supporting sequential gross margin improvement in 2026.
- Efficiency Innovation Portfolio: Over a dozen automation projects are set to deliver $5-6M in 2026 cost savings, scaling to $20-24M in 2027.
With a full exit from migrant-related revenue, DocGo’s financials now better reflect its ongoing business and margin potential. Management raised 2026 revenue and EBITDA guidance, citing visibility from current contracts and hiring progress.
Executive Commentary
"We are seeing an absolutely stellar performance from our virtual care offering, SteadyMD. During the fourth quarter, SteadyMD exceeded $8 million in revenue for the first time in its history, beating the previous quarterly high by approximately $1 million... Our integration efforts remain on track, and we are aiming to consolidate provider networks so that SteadyMD clinicians will be able to provide care for patients across DOTCO's mobile health offerings by the end of the second quarter."
Lee Beanstock, Chief Executive Officer
"Our cash balance at year-end was lower than we had expected due to the delay in collecting migrant-related accounts receivable owed by New York City's Department of Housing Preservation and Development... With further operating losses expected during the first half of 2026 and several growth-related initiatives requiring working capital, we would expect further declines in cash in the near term, creating potential working capital pressure during 2026. To mitigate this, we are highly focused on reducing cash utilization and operating costs, particularly at the corporate level."
Norm, Chief Financial Officer
Strategic Positioning
1. Virtual Care Platform Expansion
SteadyMD, DocGo’s virtual care acquisition, is now a foundational growth engine. The business posted record revenue and margin expansion, with management targeting further integration by leveraging SteadyMD’s clinician network across all mobile health offerings. Major customer expansions, especially for branded GLP-1 weight loss programs, are fueling volume and revenue visibility.
2. Operational Leverage Through Hiring and Automation
Medical transportation’s margin profile is improving as EMT and paramedic hiring reduces overtime dependency. The company filled 206 out of 546 open roles, and overtime rates are trending down, which is expected to lift gross margins. Automation initiatives—such as agentic AI in patient outreach and pre-billing—are being rolled out to further compress SG&A.
3. Recurring Payer and Health System Growth
DocGo is deepening relationships with national insurance payers, expanding care gap closure programs into new states and increasing assigned lives to over 1.45 million. Cross-sell opportunities—converting care gap patients into longitudinal primary care relationships—are a significant untapped lever as the company’s service portfolio matures.
4. Efficiency Innovation Portfolio
The efficiency innovation portfolio, a suite of automation and workflow projects, is expected to deliver $5-6 million in 2026 cost savings and scale to $20-24 million in 2027. These initiatives target medical transportation, mobile health, and corporate functions, aiming to create durable operating leverage as the business scales.
5. Strategic Alternatives Process
Management disclosed initiation of a formal process to explore strategic alternatives, including a potential sale or other value-maximizing transactions. This signals openness to structural change and could catalyze further re-rating if successful, though no assurance of outcome was given.
Key Considerations
DocGo’s 2025 exit from migrant programs and rapid SteadyMD integration mark a structural shift toward higher-quality, recurring healthcare revenue streams. The quarter’s results and guidance update highlight a business increasingly focused on operational discipline, payer channel depth, and technology-enabled efficiency.
Key Considerations:
- Margin Leverage Through Labor and Mix: Overtime reduction and mix shift to higher-margin services are central to EBITDA improvement.
- Visibility Anchored in Existing Contracts: 2026 guidance is based on current staffing and customer agreements, with upside from new wins not yet included.
- Strategic Alternatives as a Wildcard: The outcome of the ongoing strategic review could reshape DocGo’s capital structure or ownership profile.
- Working Capital Tightness: Delays in receivables collection and ongoing operating losses create near-term cash pressure, requiring tight cost control and credit line flexibility.
Risks
DocGo faces near-term working capital and liquidity pressure, especially as cash outflows for growth and delayed receivables intersect with ongoing operating losses. Execution risk remains around EMT hiring, automation project delivery, and payer contract expansion. Additionally, the outcome and timing of the strategic alternatives process is uncertain, and any shortfall in margin or volume recovery could delay the path to profitability.
Forward Outlook
For Q1 2026, DocGo guided to:
- Continued sequential improvement in gross margin as overtime rates decline
- Adjusted EBITDA losses concentrated in the first half, with profitability targeted in the second half
For full-year 2026, management raised guidance:
- Revenue of $290M to $310M (up from $280M to $300M prior)
- Adjusted EBITDA loss of $5M to $10M (improved from $15M to $25M loss)
Management highlighted several factors that underpin this outlook:
- Upside from SteadyMD volume and integration
- Ongoing cost savings from automation and efficiency projects
Takeaways
DocGo’s business mix reset and efficiency drive are laying the foundation for margin expansion and eventual profitability.
- Virtual Care and Transportation Scale: SteadyMD and core transportation are now the primary growth and margin engines, with recurring revenue visibility and expanding payer relationships.
- Efficiency and Automation Critical: Technology projects and labor improvements are essential for SG&A compression and margin leverage, with cost savings expected to compound into 2027.
- Strategic Review Adds Optionality: The formal process for strategic alternatives introduces potential for structural change, but execution and timing remain uncertain.
Conclusion
DocGo’s Q4 marks a turning point as SteadyMD integration and operational discipline drive a reset in business quality and profitability trajectory. With legacy migrant exposure now eliminated and automation initiatives scaling, the company is positioned for margin gains and recurring revenue growth—though liquidity management will be critical in the near term.
Industry Read-Through
DocGo’s exit from one-time government programs and pivot to recurring payer and virtual care revenue is a key signal for the mobile health and medical transportation sector. The integration of virtual care platforms, automation of administrative workflows, and focus on cross-selling across payer relationships are likely to become standard for players seeking sustainable growth and margin expansion. Liquidity pressures and the need for disciplined working capital management are industry-wide concerns as healthcare services businesses scale post-pandemic. The strategic alternatives process at DocGo could spur similar moves among peers facing valuation gaps and structural headwinds.